Company profile: Seraxis
1.1 - Company Overview
Company description
- Provider of cell replacement therapy and lab-grown pancreatic islets for insulin-dependent diabetes. Offerings include SR-01, which combines lab-grown human islets with a technology to implant these islets without immune suppression; SR1423, a stem cell line maturing into insulin-secreting islets; and lab-grown islets that mimic native pancreatic function and respond to glucose.
Products and services
- SR-01: A cell replacement therapy for insulin-dependent diabetes utilizing lab-grown human islets and an immune-shielding implant technology to enable transplantation without immune suppression
- Lab-grown islets for transplant: Implant-ready islets engineered to mimic native pancreatic function, secreting insulin in response to glucose levels for physiological glycemic regulation after transplantation
- SR1423: A research-grade stem cell line architected to mature into pancreatic islets that secrete insulin and other hormones, faithfully mimicking native islet functionality
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Seraxis
Magtivio
HQ: The Netherlands
Website
- Description: Provider of magnetic micro- and nano particles and complete kits for DNA extraction, circulating cfDNA analysis, NGS library preparation, and dye-terminator removal in Sanger sequencing, as well as magnetic separators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magtivio company profile →
BioLegend
HQ: United States
Website
- Description: Provider of immunological reagents for biomedical research, developing antibodies, recombinant proteins, bioassays, and other research reagents at a state-of-the-art facility in San Diego, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLegend company profile →
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
Biocoat
HQ: United States
Website
- Description: Provider of custom-engineered biomaterial coatings for medical devices, specializing in lubricious hydrophilic coatings that deliver lubricity, durability, and low particulate counts. Services include contract coating, custom polymer synthesis, and reagent fulfillment, with specialized hydrophilic solutions for neurovascular and cardiovascular devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocoat company profile →
Seahorse Bioscience
HQ: United States
Website
- Description: Provider of analytical instruments, biomanufacturing systems, and consumable labware for biological research and drug discovery, serving scientists at academic institutions, pharmaceutical and biotech organizations, and OEM manufacturers of assay kits and lab instrument suppliers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seahorse Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Seraxis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Seraxis
2.2 - Growth funds investing in similar companies to Seraxis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Seraxis
4.2 - Public trading comparable groups for Seraxis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →